Avelead Signs RevID Agreement with MEDITECH-Based Facility
Streamline Health Company (Nasdaq: STRM) has announced an expansion in its partnership with a major healthcare system by implementing its RevID automated charge reconciliation solution. This implementation is a significant milestone as it marks RevID's entry into its first MEDITECH electronic health record customer. The RevID solution aims to prevent revenue leakage by identifying and reconciling potential charge errors before billing, enhancing accountability and performance within revenue systems.
- Expanded agreement with a major healthcare system managing over 80 facilities.
- RevID's entry into the MEDITECH market demonstrates its EHR-agnostic capability.
- The solution aims to eliminate revenue leakage, showing potential for improved financial performance.
- None.
Existing Client Expands Use of RevID’s Automated Charge Reconciliation to Help Eliminate Revenue Leakage
Atlanta, GA, May 25, 2022 (GLOBE NEWSWIRE) -- Avelead, a Streamline Health Company (Nasdaq: STRM), today announced that it has executed an agreement to implement its automated charge reconciliation solution RevID with its first MEDITECH electronic health record (“EHR”) customer. The agreement is an expansion of Avelead’s existing relationship with a prominent healthcare system that manages 80+ facilities throughout the United States.
Avelead’s flagship RevID solution eliminates revenue leakage before it happens by helping identify, review and reconcile potential charge mistakes prior to billing. In addition, RevID’s real-time visibility and control enables greater accountability within the revenue system, providing a top-down view of departmental performance.
“The expansion of RevID’s footprint into our first MEDITECH-based facility will allow us to increase our overall customer base, demonstrating the value our software provides to our healthcare system clients,” stated Jawad Shaikh, President and CEO, Avelead. “Our initial engagement with this healthcare system included facilities using other EHRs. The addition of a MEDITECH user validates the EHR-agnostic nature of RevID and its ability to help eliminate revenue leakage prior to billing. We appreciate the trust our healthcare partners continue to place in our ability to help put an end to lost revenue.”
About Avelead
Avelead, a Streamline Health Company, empowers hospitals and health systems to thrive by eliminating leaking revenue from every healthcare setting. With Avelead’s results-based software, hospitals can proactively identify discrepancies, centralize data, and confirm revenue capture for improved financial performance. Avelead’s unique healthcare solutions currently support more than 140 providers across the country.
For more information about Avelead’s services and solutions, visit www.avelead.com
About Streamline Health
Streamline Health Solutions, Inc. (Nasdaq: STRM) enables healthcare organizations to proactively address revenue leakage and improve financial performance. We deliver integrated solutions, technology-enabled services and analytics that drive compliant revenue leading to improved financial performance across the enterprise. For more information, visit www.streamlinehealth.net.
Company Contacts
Media:
David Kosloski
Director of Marketing & Communications, Avelead
David.Kosloski@avelead.com
Investors:
Jacob Goldberger
Director, Investor Relations and FP&A, Streamline Health
303-887-9625
Jacob.Goldberger@streamlinehealth.net
FAQ
What is the recent development for Streamline Health (STRM) regarding RevID?
How does RevID benefit healthcare systems?
What is the significance of the MEDITECH partnership for STRM?
